Open Access

High SPRR1A expression is associated with poor survival in patients with colon cancer

  • Authors:
    • Yu Deng
    • Xin Zheng
    • Yiyi Zhang
    • Meifang Xu
    • Chengwei Ye
    • Mengxin Lin
    • Jie Pan
    • Zongbin Xu
    • Xingrong Lu
    • Pan Chi
  • View Affiliations

  • Published online on: March 10, 2020     https://doi.org/10.3892/ol.2020.11453
  • Pages: 3417-3424
  • Copyright: © Deng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

High expression of small proline‑rich protein 1A (SPRR1A) has been shown to be associated with tumor prognosis; however, the association between SPRR1A expression and colon cancer prognosis remains unclear. The present study sought to evaluate the association between SPRR1A expression and the clinicopathological characteristics of colon cancer, and to examine its potential prognostic value. A total of 114 patients with colon cancer were included. SPRR1A expression was evaluated by immunohistochemical staining, and the association between SPRR1A expression and clinicopathological parameters was analyzed. The prognostic value of SPRR1A was analyzed by Cox regression analysis, the Oncomine database and the R2 platform. SPRR1A expression was significantly increased in cancerous tissues compared with that in adjacent non‑cancerous tissues. SPPRR1A expression was significantly associated with lymph node invasion. High SPRR1A expression was significantly associated with worse overall and disease‑free survival rate. Cox regression analysis revealed that T stage, pathological N stage and high SPRR1A expression remained independent predictors for overall survival rate. The Oncomine database analysis demonstrated that SPRR1A mRNA expression levels were significantly increased in colorectal cancer tissues compared with those in adjacent non‑cancerous tissues, and high SPRR1A expression was associated with a significantly worse event‑ and relapse‑free survival time in the R2 platform. The data indicate that SPRR1A may serve as a potential biomarker for the prognosis of colon cancer.

Related Articles

Journal Cover

May 2020
Volume 19 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Deng, Y., Zheng, X., Zhang, Y., Xu, M., Ye, C., Lin, M. ... Chi, P. (2020). High SPRR1A expression is associated with poor survival in patients with colon cancer. Oncology Letters, 19, 3417-3424. https://doi.org/10.3892/ol.2020.11453
MLA
Deng, Y., Zheng, X., Zhang, Y., Xu, M., Ye, C., Lin, M., Pan, J., Xu, Z., Lu, X., Chi, P."High SPRR1A expression is associated with poor survival in patients with colon cancer". Oncology Letters 19.5 (2020): 3417-3424.
Chicago
Deng, Y., Zheng, X., Zhang, Y., Xu, M., Ye, C., Lin, M., Pan, J., Xu, Z., Lu, X., Chi, P."High SPRR1A expression is associated with poor survival in patients with colon cancer". Oncology Letters 19, no. 5 (2020): 3417-3424. https://doi.org/10.3892/ol.2020.11453